Myomo Inc
AMEX:MYO
Myomo Inc
Other Equity
Myomo Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Myomo Inc
AMEX:MYO
|
Other Equity
-$14.4k
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Equity
$25.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Equity
$275m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Equity
-$293m
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-1%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Equity
-$7.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Equity
$16.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Myomo Inc
Glance View
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.
See Also
What is Myomo Inc's Other Equity?
Other Equity
-14.4k
USD
Based on the financial report for Dec 31, 2024, Myomo Inc's Other Equity amounts to -14.4k USD.
What is Myomo Inc's Other Equity growth rate?
Other Equity CAGR 3Y
38%
The average annual Other Equity growth rates for Myomo Inc have been 38% over the past three years .
You don't have any saved screeners yet